Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about DK:NOVO/B
Recent news which mentions DK:NOVO/B
LifeMD’s stock soars 13% as company and Medifast to create weight-management program that includes GLP-1 drugs
December 13, 2023
Tickers
LFMD
LLY
MED
NVO
Tags
LLY
NVO
LFMD
From
MarketWatch
Walmart seems to have changed its view of weight-loss drugs
December 06, 2023
Tickers
GIS
K
KO
LLY
Tags
GIS
KO
PEP
From
MarketWatch
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
December 04, 2023
Tickers
LLY
PFE
WMT
Tags
DK:NOVO/B
CH:ROG
PFE
From
MarketWatch
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
December 01, 2023
Tickers
LLY
NVO
PFE
SPX
Tags
DK:NOVO/B
SPX
PFE
From
MarketWatch
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade
November 22, 2023
Tickers
AMGN
ARKK
BFIT
COMP
Tags
LLY
VRTX
AMGN
From
MarketWatch
Hedge funds plow cash into top tech stocks leading to record levels of crowding
November 21, 2023
Tickers
AAPL
ABT
AMZN
GOOG
Tags
LLY
AAPL
META
From
MarketWatch
British Land leads U.K. real estate stocks higher amid optimism on rents
November 13, 2023
Tags
FR:PX1
UK:BLND
UK:UKX
From
MarketWatch
Weight-loss drug maker reports 56% profit surge, as it continues to limit supplies
November 02, 2023
Tickers
LLY
NVO
Tags
LLY
NVO
DK:NOVO/B
From
MarketWatch
Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait
October 31, 2023
Tickers
ABBV
AMGN
LLY
NVO
Tags
NVO
LLY
AMGN
From
MarketWatch
Who is having the most influence over your money in 2023? Meet the MarketWatch 50.
October 31, 2023
Tickers
AAPL
AMZN
BRK-B
DVA
Tags
STLA
DK:NOVO/B
MDLZ
From
MarketWatch
The weight-loss drugs are coming for these companies — but here’s why Coke, others, may be spared, says JPMorgan
October 24, 2023
Tickers
A
AAPL
AMC
AVTR
Tags
CTLT
BX:TMUBMUSD02Y
WMT
From
MarketWatch
Here’s what Ozempic, ASML and India’s fintech industry all have in common — and how one ETF takes advantage of all three
October 17, 2023
Tickers
ACWX
ASML
FERG
HDB
Tags
NVDA
SPY
DK:NOVO/B
From
MarketWatch
What exactly are patients taking new weight-loss drugs eating and what are they avoiding? Bernstein asked them.
October 13, 2023
Tickers
CPB
GIS
HSY
K
Tags
SPX
TSN
K
From
MarketWatch
DaVita plays down Ozempic’s potential in treating kidney disease
October 12, 2023
Tickers
DVA
SPX
Tags
SPX
DK:NOVO/B
DVA
From
MarketWatch
LVMH shares slump on sales miss, sending rival luxury-goods makers lower
October 11, 2023
Tags
UK:BRBY
FR:PX1
XX:SXXP
From
MarketWatch
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
October 11, 2023
Tickers
FMS
LLY
NVS
Tags
DK:NOVO/B
XE:FME
FMS
From
MarketWatch
Coca-Cola and PepsiCo’s stocks fall after Walmart says weight-loss drugs have customers cutting back on calories
October 06, 2023
Tickers
LLY
NVO
PEP
SPX
Tags
SPX
WMT
LLY
From
MarketWatch
This fund shows that industry expertise can help you make a lot of money in the stock market
October 02, 2023
Tickers
ABBV
ABT
AKRO
ETNB
Tags
AKRO
MRK
FR:SAN
From
MarketWatch
Novo Nordisk, now Europe’s second-largest company by market cap, lifts outlook after 46% profit rise
August 10, 2023
Tickers
NVO
Tags
NVO
DK:NOVO/B
From
MarketWatch
Viking Therapeutics stock gets boost from positive news that obesity drugs reduced risk of heart attacks and strokes
August 09, 2023
Tickers
LLY
NVO
SPX
VKTX
Tags
DK:NOVO/B
NVO
VKTX
From
MarketWatch
As obesity drugs help people eat less, these food companies could be the biggest losers
August 08, 2023
Tickers
ACI
BJ
BRBR
CAVA
Tags
WING
GO
VITL
From
MarketWatch
Eli Lilly’s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook
August 08, 2023
Tickers
DJIA
JNJ
LLY
MRK
Tags
DK:NOVO/B
MRK
JNJ
From
MarketWatch
Novo Nordisk’s Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults
August 08, 2023
Tickers
LLY
NVO
PFE
Tags
DK:NOVO/B
NVO
LLY
From
MarketWatch
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
July 21, 2023
Tickers
ALT
CTLT
GPCR
LLY
Tags
UK:AZN
ALT
XE:GXI
From
MarketWatch
EU regulator is reviewing weight-loss drugs Ozempic and Wegovy for risk of suicidal thoughts and self-harm
July 11, 2023
Tickers
LLY
PFE
Tags
DK:NOVO/B
LLY
PFE
From
MarketWatch
Ozempic and other weight-loss drugs boost pharmacy sales at Rite Aid
June 29, 2023
Tickers
LLY
PFE
RAD
Tags
PFE
LLY
DK:NOVO/B
From
MarketWatch
Student-loan payments are coming back — and these are the stocks most at risk
June 20, 2023
Tickers
AAPL
AEO
AMC
BABA
Tags
XPEV
BABA
HK:1060
From
MarketWatch
Hit Wegovy weight-loss drug on track for $4 billion in U.S. sales despite supply constraints, analyst says
June 20, 2023
Tickers
LLY
NVO
Tags
NVO
LLY
DK:NOVO/B
From
MarketWatch
Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval
February 13, 2023
Tickers
ETNB
GNFT
ICPT
LLY
Tags
DK:NOVO/B
GNFT
VKTX
From
MarketWatch
Lilly’s ambitious diabetes drug Mounjaro fails to impress in the fourth quarter
February 02, 2023
Tickers
LLY
SPX
Tags
LLY
SPX
DK:NOVO/B
From
MarketWatch
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.